TScan Therapeutics

TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. The company develops T-cell-based treatments in immuno-oncology using its technology: TargetScan and ReceptorScan. The TCR-T therapy candidates are manufactured using a transposon system, in which the DNA encoding the TCR is manufactured as a Nanoplasmid, a non-viral vector.